1. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). Issue 1 (April 2015) Authors: Kotsakis, A.; Kentepozidis, N.; Emmanouilidis, Ch.; Polyzos, A.; Agelidou, A.; Vaslamatzis, M.; Chandrinos, V.; Agelaki, S.; Vamvakas, L.; Kalbakis, K.; Katsaounis, P.; Stoltidis, D.; Nintos, G.; Hatzidaki, D.; Vetsika, E.K.; Mavroudis, D.; Georgoulias, V. Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). Issue 1 (April 2015) Authors: Kotsakis, A.; Kentepozidis, N.; Emmanouilidis, Ch.; Polyzos, A.; Agelidou, A.; Vaslamatzis, M.; Chandrinos, V.; Agelaki, S.; Vamvakas, L.; Kalbakis, K.; Katsaounis, P.; Stoltidis, D.; Nintos, G.; Hatzidaki, D.; Vetsika, E.K.; Mavroudis, D.; Georgoulias, V. Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗